16.8K(top 2%)
articles
623.7K(top 2%)
citations
4,612(top 2%)
★★ articles
222(top 2%)
★★★ articles
2.6(top 19%)
Avg IF
285(top 2%)
H-Index
465(top 2%)
G-Index
4,143
journals

Most Cited Articles of Royal Marsden Hospital in 2010

TitleJournalYearCitations
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathwayAnnual Review of Biochemistry20101.9K
SPECTRA ANDHUBBLE SPACE TELESCOPELIGHT CURVES OF SIX TYPE Ia SUPERNOVAE AT 0.511 Astrophysical Journal20101K
Tumor-associated macrophages and survival in classic Hodgkin's lymphomaNew England Journal of Medicine2010961
Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptorScience Signaling2010903
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force CriteriaEuropean Heart Journal2010889
Effects of medical therapies on retinopathy progression in type 2 diabetesNew England Journal of Medicine2010859
Diffusion-weighted MR imaging of the liverRadiology2010621
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifenJournal of Clinical Oncology2010615
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC studyJournal of Clinical Oncology2010547
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerCancer Research2010533
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementLeukemia2010505
Pathogenetic mechanisms in radiation fibrosisRadiotherapy and Oncology2010397
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trialInternational Journal of Cancer2010383
The Supernova Legacy Survey 3-year sample: Type Ia supernovae photometric distances and cosmological constraintsAstronomy and Astrophysics2010339
Current and emerging biomarkers in breast cancer: prognosis and predictionEndocrine-Related Cancer2010320
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicineBritish Journal of Cancer2010312
SHED differentiate into functional odontoblasts and endotheliumJournal of Dental Research2010302
Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotalineArteriosclerosis, Thrombosis, and Vascular Biology2010279
Cancer biomarkers: can we turn recent failures into success?Journal of the National Cancer Institute2010277
Guidelines on the radical management of patients with lung cancerThorax2010274
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of lifeSupportive Care in Cancer2010264
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trialLancet Oncology, The2010262
Revised U.K. guidelines for the management of cutaneous melanoma 2010British Journal of Dermatology2010259
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2010247
A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancerClinical Cancer Research2010240